Companies: 10,795·Total market cap: $144.5T
The Oncology Institute, Inc.

The Oncology Institute, Inc.

TOINASDAQHealthcare● Active
$5.07
+$0.20(+4.11%)
Market Cap$506913303
P/E Ratio
52W High$5.575
52W Low$2.015
Overview

The Oncology Institute, Inc. (TOI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · TOI · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.35toi eps ttm · toi earnings per shareEarnings history
PE Ratio (TTM)toi pe ratio ttm · toi price to earningsPE Ratio deep dive
Revenue (TTM)$545.8Mtoi revenue ttm · toi annual revenueFull revenue history
Dividend YieldNo Dividenddoes toi pay dividends · toi dividend yieldDividend history
Shares Outstanding923.9Mtoi shares outstanding · toi floatShares outstanding history
Next EarningsAug 12, 2026Est.toi earnings date · toi next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$502.7M▲ +27.79% YoY
202320242025
the oncology institute, inc. revenue · toi revenue 2025
FY 2025Net Income-$60.6M▲ +6.27% YoY
202320242025
the oncology institute, inc. net income · toi profit 2025
FY 2025EPS$-0.54▲ +23.94% YoY
202320242025
toi eps · the oncology institute, inc. earnings per share 2025
TTM:Revenue: $545.8MNet Income: -$43.5MEPS: $-0.35View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis toi a buy · toi analyst rating
Strong Buy
0
Buy
5
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$8.00Low
$5.07Current
$8.00Avg Target57.79% upside
$8.00High
toi price target · toi 12 month forecast

Total: 5 · Buy rate: 100.0%

The TOI analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $8.00, representing +57.79% upside from the current price of $5.07.

Stock Performance

Full History
1D+4.11%
1W+11.43%
1M+26.75%
3M+82.37%
YTD+42.42%
1Y+95.00%
5Y-49.55%

About The Oncology Institute, Inc.

CEODaniel Virnich
IPO DateJun 4, 2020
Employees825
CountryUS

The Oncology Institute, Inc. The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physicia…

what is the oncology institute, inc. · toi stock overview · the oncology institute, inc. company profile · who is the oncology institute, inc. ceo · toi NASDAQ · the oncology institute, inc. headquarters · the oncology institute, inc. business segments

About Stock Overview & Key Data

The Oncology Institute, Inc. (TOI) is a Healthcare company in the Medical - Care Facilities industry, listed on NASDAQ since Jun 4, 2020. As of the latest trading session, TOI stock price is $5.07, with a market capitalization of $506.9M. The stock has returned +95.00% over the past 12 months and +42.42% year-to-date.

According to 5 Wall Street analysts, the consensus rating for The Oncology Institute, Inc. stock is Buy, with an average 12-month price target of $8.00. In fiscal year 2025, The Oncology Institute, Inc. reported revenue of $502.7M and net income of -$60.6M. For detailed data — including The Oncology Institute, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, The Oncology Institute, Inc. (TOI) stock price is $5.07. The stock is traded on NASDAQ under the ticker symbol TOI. The 52-week range is $2.02 – $5.58.

TOI stock priceTOI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice